Oligomerix
Biotechnology, 2 Westchester Park Dr, White Plains, New York, 10604, United States, 11-50 Employees
Phone Number: 91********
Who is OLIGOMERIX
Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein ranging from rare...
Read More
-
Headquarters: 2 Westchester Park Dr, White Plains, New York, 10604, United States
-
Date Founded: 2006
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
-
CEO:
James Moe
Email
Phone
Industry: Biotechnology
SIC Code: 5912
|
NAICS Code: 456110 |
Show More
Does something look wrong? Fix it. | View contact records from OLIGOMERIX
Oligomerix Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Oligomerix
Answer: Oligomerix's headquarters are located at 2 Westchester Park Dr, White Plains, New York, 10604, United States
Answer: Oligomerix's phone number is 91********
Answer: Oligomerix's official website is https://oligomerix.com
Answer: Oligomerix's revenue is $1 Million to $5 Million
Answer: Oligomerix's SIC: 5912
Answer: Oligomerix's NAICS: 456110
Answer: Oligomerix has 11-50 employees
Answer: Oligomerix is in Biotechnology
Answer: Oligomerix contact info: Phone number: 91******** Website: https://oligomerix.com
Answer: Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein ranging from rare tauopathies such as progressive supranuclear palsy and frontotemporal dementia to Alzheimers disease. With a focus on oral, small molecule, tau self-association inhibitors, Oligomerix seeks to develop therapies for Alzheimers disease and other dementias that are easy to administer and cost effective, and which are expected to significantly add to newly emerging high-cost therapeutic options such as the monoclonal antibody targeted against beta-amyloid that was recently approved by the U.S. FDA. Oligomerix is headquartered at the Westchester Park Center in White Plains, New York and has lab facilities at the Ullmann Research Center for Health Sciences within the Albert Einstein College of Medicine.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month